BIOMEDevice San Jose 2019 Announces Esteemed Lineup of Keynote Panelists Set to Address the Growth of The Digital Health Market
September 03, 2019 11:02 ET
|
BioMEDDevice / ESC San Jose
SANTA MONICA, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- BIOMEDevice San Jose, Silicon Valley’s premier event for medical technology professionals, today announced its 2019 keynote panel will...
Co-Diagnostics CEO Opens up on Goals and Milestones in Interview with Wall Street Analyzer
August 29, 2019 07:00 ET
|
BDA International
New York City, New York, Aug. 29, 2019 (GLOBE NEWSWIRE) -- The Wall Street Analyzer recently completed and published an interview with the CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular...
Axiom Real-Time Metrics Showcasing Fusion eClinical Suite at DeviceFest & Digital Heath Conference in Southern California
August 28, 2019 11:26 ET
|
Axiom Real-Time Metrics Inc
TORONTO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is exhibiting today at Biocom’s annual DeviceFest and...
Achieve TMS, the second largest TMS group in the US, starts using Nexstim SmartFocus® TMS technology
August 26, 2019 02:30 ET
|
Nexstim Oyj
Press release, Helsinki, 26 August 2019 at 9.30 am (EET) Achieve TMS, the second largest TMS group in the US, starts using Nexstim SmartFocus® TMS technology Nexstim Plc (NXTMH:HEX, NXTMS:STO)...
Nexstim reports good initial results on the use of Smartfocus® technology in treatment of major depressive disorder
August 20, 2019 03:00 ET
|
Nexstim Oyj
Press Release, Helsinki, 20 August 2019 at 10.00 am (EET) Nexstim reports good initial results on the use of Smartfocus® technology in treatment of major depressive disorder Nexstim Plc...
NEXSTIM ABP:S HALVÅRSRAPPORT 1/1–30/6 2019 (OREVIDERAD)
August 16, 2019 02:00 ET
|
Nexstim Oyj
Pressmeddelande, Helsingfors 16 augusti 2019 kl. 9.00 Viktiga händelser januari–juni 2019 Fokusering på terapistrategi för depressionsbehandling. God framgång genom åtta nya NBT®-system som tagits i...
NEXSTIM OYJ:N PUOLIVUOSIKATSAUS 1.1–30.6.2019 (TILINTARKASTAMATON)
August 16, 2019 02:00 ET
|
Nexstim Oyj
Yhtiötiedote, Helsinki, 16.8.2019 klo 9.00 Kohokohdat tammi-kesäkuussa 2019 Keskittyminen masennuksen hoitoa toteuttavaan terapiastrategian. Hyvä edistyminen asentamalla klinikoille kahdeksan uutta...
NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY – 30 JUNE 2019 (UNAUDITED)
August 16, 2019 02:00 ET
|
Nexstim Oyj
Company announcement, Helsinki, 16 August 2019 at 9:00 am Highlights, January – June 2019 Focused on executing our depression-led therapy strategy. Good progress with a total of eight new NBT®...
Publicering av Nexstim Abp:s halvårsrapport för H1 2019
August 12, 2019 02:00 ET
|
Nexstim Oyj
Pressmeddelande, Helsingfors den 12 augusti 2019 kl. 9.00 (EEST) Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolaget”), ett företag inom riktad neuromodulering som tagit fram och marknadsför...
Nexstim Oyj:n puolivuotiskatsauksen H1 2019 julkistus
August 12, 2019 02:00 ET
|
Nexstim Oyj
Yhtiötiedote, Helsinki, 12.8.2019 klo 9.00 (EEST) Nexstim Oyj (NXTMH:HEX, NXTMS:STO) (”Nexstim” tai ”Yhtiö”) on neuromodulaatioyritys, joka on kehittänyt markkinoimansa uraauurtavan kallon...